Neuroblastoma in a 55-Year-Old Patient: A Case Report

por Then, Cornelia, Ebelt, Kathleen, Langer, Alexandra, Mayr, Doris, Schmidmaier, Ralf, Oduncu, Fuat
Publicado 2010

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients

por Li, Pan, Xiao, Zhitao, Braciak, Todd A., Ou, Qingjian, Chen, Gong, Oduncu, Fuat S.
Publicado 2017

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival

por Li, Pan, Xiao, Zhitao, Braciak, Todd A., Ou, Qingjian, Chen, Gong, Oduncu, Fuat S.
Publicado 2017

Impact of age and mismatch repair status on survival in colorectal cancer

por Li, Pan, Xiao, Zhi‐Tao, Braciak, Todd A., Ou, Qing‐Jian, Chen, Gong, Oduncu, Fuat S.
Publicado 2017

Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model

por Roehnisch, Tim, Then, Cornelia, Nagel, Wolfgang, Blumenthal, Christina, Braciak, Todd, Donzeau, Mariel, Böhm, Thomas, Bourquin, Carole, Oduncu, Fuat
Publicado 2013

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma

por Roehnisch, Tim, Then, Cornelia, Nagel, Wolfgang, Blumenthal, Christina, Braciak, Todd, Donzeau, Mariel, Böhm, Thomas, Flaig, Michael, Bourquin, Carole, Oduncu, Fuat S
Publicado 2014

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells

por Roskopf, Claudia C., Braciak, Todd A., Fenn, Nadja C., Kobold, Sebastian, Fey, Georg H., Hopfner, Karl-Peter, Oduncu, Fuat S.
Publicado 2016

NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM...

por Braciak, Todd A, Wildenhain, Sarah, Roskopf, Claudia C, Schubert, Ingo A, Fey, Georg H, Jacob, Uwe, Hopfner, Karl-Peter, Oduncu, Fuat S
Publicado 2013

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell

por Roskopf, Claudia C., Schiller, Christian B., Braciak, Todd A., Kobold, Sebastian, Schubert, Ingo A., Fey, Georg H., Hopfner, Karl-Peter, Oduncu, Fuat S.
Publicado 2014

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells

por Schiller, Christian B., Braciak, Todd A., Fenn, Nadja C., Seidel, Ursula J. E., Roskopf, Claudia C., Wildenhain, Sarah, Honegger, Annemarie, Schubert, Ingo A., Schele, Alexandra, Lämmermann, Kerstin, Fey, Georg H., Jacob, Uwe, Lang, Peter, Hopfner, Karl-Peter, Oduncu, Fuat S.
Publicado 2016

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural kille...

por Braciak, Todd A., Roskopf, Claudia C., Wildenhain, Sarah, Fenn, Nadja C., Schiller, Christian B., Schubert, Ingo A., Jacob, Uwe, Honegger, Annemarie, Krupka, Christina, Subklewe, Marion, Spiekermann, Karsten, Hopfner, Karl-Peter, Fey, Georg H., Aigner, Michael, Krause, Stefan, Mackensen, Andreas, Oduncu, Fuat S.
Publicado 2018